Health In Tech executives extend share lock-up period by six months

Published 02/12/2025, 14:36
Health In Tech executives extend share lock-up period by six months

STUART, Fla. - Health In Tech (NASDAQ:HIT), an Insurtech platform company, announced Tuesday that its executive management team, vice presidents, and board of directors have voluntarily agreed to extend the lock-up restrictions on their shares for an additional six months. The company’s stock, currently trading at $1.63, has shown significant volatility with a 13% gain over the past week despite falling 68% over the last year, according to InvestingPro data.

The extension moves the lock-up expiration date from December 20, 2025, to June 20, 2026, beyond the original twelve-month restriction established following the company’s initial public offering last December.

"Our leadership team remains highly committed to the long-term growth of Health In Tech," said Tim Johnson, CEO of Health In Tech, in a press release statement.

Health In Tech completed its IPO in December 2024, raising gross proceeds of $9.2 million. According to the company, it has since continued investing in system enhancements, broadening its distribution network, and expanding service offerings across the self-funded healthcare ecosystem.

The company describes itself as an Insurtech platform backed by third-party AI technology that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation.

The lock-up extension affects all shares currently held by the company’s executive officers and board members, preventing them from selling or transferring these shares for the extended period.

In other recent news, Health In Tech, Inc. reported significant growth in its third-quarter earnings, with a 90% year-over-year increase in revenue, reaching $8.5 million. The company’s earnings per share met expectations at $0.01, as discussed in their recent earnings call. These financial results were detailed in a conference call, with a transcript available on the company’s website for further review. Additionally, Health In Tech announced the termination of Imran Yousuf from his role as chief technology officer. The termination was without cause and not due to any disagreements related to company operations or policies. This leadership change was disclosed in a filing with the Securities and Exchange Commission. No further details were provided about plans for filling the CTO position. These recent developments reflect ongoing changes and growth within the company.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.